NCT01347645 2023-06-22Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal CancerEisai Inc.Phase 1/2 Terminated82 enrolled 14 charts